Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hochhaus, A., Saussele, S., Rosti, G., Mahon, F.-X., Janssen, J.J.W.M., Hjorth-Hansen, H., Richter, J., Buske, C.
Published in Annals of oncology (01.07.2017)
Published in Annals of oncology (01.07.2017)
Get full text
Journal Article
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial
Prey, S., Ezzedine, K., Doussau, A., Grandoulier, A.-S., Barcat, D., Chatelus, E., Diot, E., Durant, C., Hachulla, E., de Korwin-Krokowski, J.-D., Kostrzewa, E., Quemeneur, T., Paul, C., Schaeverbeke, T., Seneschal, J., Solanilla, A., Sparsa, A., Bouchet, S., Lepreux, S., Mahon, F.-X., Chene, G., Taïeb, A.
Published in British journal of dermatology (1951) (01.11.2012)
Published in British journal of dermatology (1951) (01.11.2012)
Get full text
Journal Article
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study
Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Published in Leukemia (01.01.2016)
Published in Leukemia (01.01.2016)
Get full text
Journal Article
Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi( )-LMC GROUP)
NICOLINI, F. E, CORM, S, FACON, T, MAHON, F.-X, CAYUELA, J.-M, ROUSSELOT, P, MICHALLET, M, PREUDHOMME, C, GUILHOT, F, ROCHE-LESTIENNE, C, LE, Q.-H, SOREL, N, HAYETTE, S, BORIES, D, LEGUAY, T, ROY, L, GIRAUDIER, S, TULLIEZ, M
Published in Leukemia (01.06.2006)
Published in Leukemia (01.06.2006)
Get full text
Journal Article
Proposed diagnostic criteria and classification of basophilic leukemias and related disorders
Valent, P, Sotlar, K, Blatt, K, Hartmann, K, Reiter, A, Sadovnik, I, Sperr, W R, Bettelheim, P, Akin, C, Bauer, K, George, T I, Hadzijusufovic, E, Wolf, D, Gotlib, J, Mahon, F-X, Metcalfe, D D, Horny, H-P, Arock, M
Published in Leukemia (01.04.2017)
Published in Leukemia (01.04.2017)
Get full text
Journal Article
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Ilander, M, Olsson-Strömberg, U, Schlums, H, Guilhot, J, Brück, O, Lähteenmäki, H, Kasanen, T, Koskenvesa, P, Söderlund, S, Höglund, M, Markevärn, B, Själander, A, Lotfi, K, Dreimane, A, Lübking, A, Holm, E, Björeman, M, Lehmann, S, Stenke, L, Ohm, L, Gedde-Dahl, T, Majeed, W, Ehrencrona, H, Koskela, S, Saussele, S, Mahon, F-X, Porkka, K, Hjorth-Hansen, H, Bryceson, Y T, Richter, J, Mustjoki, S
Published in Leukemia (01.05.2017)
Published in Leukemia (01.05.2017)
Get full text
Journal Article
Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
Hughes, T P, Leber, B, Cervantes, F, Spector, N, Pasquini, R, Clementino, N C D, Schwarer, A P, Dorlhiac-Llacer, P E, Mahon, F-X, Rea, D, Guerci-Bresler, A, Kamel-Reid, S, Bendit, I, Acharya, S, Glynos, T, Dalal, D, Branford, S, Lipton, J H
Published in Leukemia (01.11.2017)
Published in Leukemia (01.11.2017)
Get full text
Journal Article
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
Giles, F J, Kantarjian, H M, le Coutre, P D, Baccarani, M, Mahon, F-X, Blakesley, R E, Gallagher, N J, Gillis, K, Goldberg, S L, Larson, R A, Hochhaus, A, Ottmann, O G
Published in Leukemia (01.05.2012)
Published in Leukemia (01.05.2012)
Get full text
Journal Article
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
Roche-Lestienne, C, Marceau, A, Labis, E, Nibourel, O, Coiteux, V, Guilhot, J, Legros, L, Nicolini, F, Rousselot, P, Gardembas, M, Helevaut, N, Frimat, C, Mahon, F-X, Guilhot, F, Preudhomme, C
Published in Leukemia (01.10.2011)
Published in Leukemia (01.10.2011)
Get full text
Journal Article
PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor
Airiau, K, Mahon, F-X, Josselin, M, Jeanneteau, M, Belloc, F
Published in Cell death & disease (01.10.2013)
Published in Cell death & disease (01.10.2013)
Get full text
Journal Article
First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia
Rea, D, Etienne, G, Nicolini, F, Cony-Makhoul, P, Johnson-Ansah, H, Legros, L, Huguet, F, Tulliez, M, Gardembas, M, Bouabdallah, K, Rousselot, P, Cayuela, J-M, Guilhot, F, Mahon, F-X
Published in Leukemia (01.10.2012)
Published in Leukemia (01.10.2012)
Get full text
Journal Article
Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Charaf, L, Mahon, F-X, Lamrissi-Garcia, I, Moranvillier, I, Beliveau, F, Cardinaud, B, Dabernat, S, de Verneuil, H, Moreau-Gaudry, F, Bedel, A
Published in Leukemia (01.01.2017)
Published in Leukemia (01.01.2017)
Get full text
Journal Article
From in vitro to in vivo: intracellular determination of imatinib and nilotinib may be related with clinical outcome
Bouchet, S, Dulucq, S, Pasquet, J-M, Lagarde, V, Molimard, M, Mahon, F-X
Published in Leukemia (01.08.2013)
Published in Leukemia (01.08.2013)
Get full text
Journal Article
Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence
Drullion, C, Trégoat, C, Lagarde, V, Tan, S, Gioia, R, Priault, M, Djavaheri-Mergny, M, Brisson, A, Auberger, P, Mahon, F-X, Pasquet, J-M
Published in Cell death & disease (01.08.2012)
Published in Cell death & disease (01.08.2012)
Get full text
Journal Article
Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials
le Coutre, P D, Hughes, T P, Mahon, F-X, Kim, D-W, Steegmann, J L, Shah, N P, Gooden, K, Wallis, N, Cortes, J E
Published in Leukemia (01.07.2016)
Published in Leukemia (01.07.2016)
Get full text
Journal Article
Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia
POCALY, M, LAGARDE, V, DUPOUY, M, TURCQ, B, MAHON, F.-X, PASQUET, J.-M, ETIENNE, G, RIBEIL, J.-A, CLAVEROL, S, BONNEU, M, MOREAU-GAUDRY, F, GUYONNET-DUPERAT, V, HERMINE, O, MELO, J. V
Published in Leukemia (01.01.2007)
Published in Leukemia (01.01.2007)
Get full text
Journal Article
The stem cell factor-c-KIT pathway must be inhibited to enable apoptosis induced by BCR-ABL inhibitors in chronic myelogenous leukemia cells
Belloc, F, Airiau, K, Jeanneteau, M, Garcia, M, Guérin, E, Lippert, E, Moreau-Gaudry, F, Mahon, F-X
Published in Leukemia (01.04.2009)
Published in Leukemia (01.04.2009)
Get full text
Journal Article
Imatinib mesilate inhibits melanogenesis in vitro
Cario-André, M., Ardilouze, L., Pain, C., Gauthier, Y., Mahon, F-X., Taieb, A.
Published in British journal of dermatology (1951) (01.08.2006)
Published in British journal of dermatology (1951) (01.08.2006)
Get full text
Journal Article